Star Health & Allied Insurance Company Ltd

Star Health & Allied Insurance Company Ltd has experienced a subtle but notable shift in its technical momentum, moving from a mildly bearish stance to a mildly bullish outlook. This change is underscored by a complex interplay of technical indicators, including MACD, RSI, moving averages, and others, reflecting a nuanced market sentiment for this small-cap insurance stock.

The 50-day moving average has crossed above the 200-day moving average for Star Health & Allied Insurance Company Ltd, signalling a golden cross on 20 Mar 2026. Yet, the stock’s modest 0.10% gain on the day and a patchwork of bullish and bearish technical indicators suggest the signal is far from definitive — is this a genuine shift in momentum or a technical artefact?

Star Health & Allied Insurance Company Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 20 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 March 2026, providing investors with the latest insights into its performance and outlook.

Star Health & Allied Insurance Company Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The stock’s recent downgrade to a 'Sell' rating by MarketsMOJO reflects deteriorating price action and weakening technical parameters, underscoring challenges for investors amid a broader insurance sector backdrop.

Star Health & Allied Insurance Company Ltd is rated 'Sell' by MarketsMOJO. This rating was last updated on 20 February 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are current as of 06 March 2026, providing investors with the latest view of the company’s position in the market.

Star Health & Allied Insurance Company Ltd has experienced a subtle but notable shift in its technical momentum, moving from a mildly bullish to a mildly bearish stance. Despite a recent price uptick, key technical indicators suggest caution for investors as the stock navigates a complex market environment.

Star Health & Allied Insurance Company Ltd has recently formed a Death Cross, a significant technical indicator where the 50-day moving average (DMA) crosses below the 200-DMA. This development signals a potential shift towards a bearish trend, raising concerns about the stock's medium to long-term momentum and investor sentiment.

Star Health & Allied Insurance Company Ltd has experienced a subtle shift in its technical momentum, moving from a sideways trend to a mildly bullish stance on daily charts. Despite this, several key indicators present a mixed picture, reflecting cautious optimism amid prevailing bearish signals on longer timeframes.

Star Health & Allied Insurance Company Ltd has seen its investment rating downgraded from Hold to Sell, driven primarily by deteriorating technical indicators and stretched valuation metrics. Despite a respectable one-year stock return of 16.14%, the company’s financial trends and quality parameters have raised concerns, prompting a reassessment of its investment appeal.

Star Health & Allied Insurance Company Ltd has experienced a notable shift in its technical momentum, transitioning from a mildly bullish stance to a sideways trend. Despite a recent downgrade in its Mojo Grade from Hold to Sell, the stock’s technical indicators present a complex picture, with bearish signals on longer timeframes contrasting with some short-term bullish cues. This article analyses the latest technical parameters, price movements, and relative performance against the Sensex to provide a comprehensive view for investors.

Star Health & Allied Insurance Company Ltd is rated 'Hold' by MarketsMOJO. This rating was last updated on 30 January 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 13 February 2026, providing investors with the latest perspective on the company’s performance and valuation.

Star Health & Allied Insurance Company Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a stabilisation in its financial performance and a shift towards a more positive technical outlook. Despite challenges in profitability and valuation concerns, the company’s recent quarterly results and market behaviour have prompted analysts to revise their stance, signalling cautious optimism for investors.

Star Health & Allied Insurance Company Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish to a mildly bullish trend on the daily charts. Despite mixed signals from key technical indicators such as MACD, RSI, and moving averages, the stock’s recent price action and relative strength against the Sensex suggest cautious optimism among investors.

Star Health & Allied Insurance Company Ltd is rated 'Hold' by MarketsMOJO. This rating was last updated on 30 January 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock’s current position as of 31 January 2026, providing investors with the most up-to-date analysis.

Star Health and Allied Insurance Company Ltd. reported a net profit of ₹128.22 crores for Q3 FY26, marking a robust sequential improvement of 133.55% from Q2 FY26's ₹54.90 crores. However, the year-on-year comparison reveals a more sobering reality, with profits declining 40.40% from ₹215.14 crores in Q3 FY25. The ₹25,442 crore market capitalisation health insurer continues to navigate a challenging landscape where premium growth comes at the cost of profitability margins, raising concerns about sustainable earnings quality in India's fiercely competitive standalone health insurance segment.

Star Health & Allied Insurance Company Ltd has been downgraded from a Sell to a Strong Sell rating as of 19 Jan 2026, reflecting deteriorating technical indicators and disappointing financial performance. The company’s Mojo Score has declined to 27.0, signalling heightened caution for investors amid a challenging market environment and weakening fundamentals.